Journal of Shandong University (Health Sciences) ›› 2024, Vol. 62 ›› Issue (2): 120-124.doi: 10.6040/j.issn.1671-7554.0.2023.1137
• 病例报道 • Previous Articles
CLC Number:
| [1] Blanchard A, Bockenhauer D, Bolignano D, et al. Gitelman syndrome: consensus and guidance from a Kidney Disease: improving Global Outcomes(KDIGO)Controversies Conference[J]. Kidney Int, 2017, 91(1): 24-33. [2] Komori H, Yamada K, Tamai I. Hyperuricemia enhances intracellular urate accumulation via down-regulation of cell-surface BCRP/ABCG2 expression in vascular endothelial cells[J]. Biochim Biophys Acta Biomembr, 2018, 1860(5): 973-980. [3] Glaudemans B, Yntema HG, San-Cristobal P, et al. Novel NCC mutants and functional analysis in a new cohort of patients with Gitelman syndrome[J]. Eur J Hum Genet, 2012, 20(3): 263-270. [4] Takeuchi Y, Mishima E, Shima H, et al. Exonic mutations in the SLC12A3 gene cause exon skipping and premature termination in Gitelman syndrome[J]. J Am Soc Nephrol, 2015, 26(2): 271-279. [5] Qi WT, Yin ZN, Liang HT, et al. Na-Cl Co-transporter(NCC)gene inactivation is associated with improved bone microstructure[J]. Osteoporos Int, 2022, 33(10): 2193-2204. [6] Puttnam R, Davis BR, Pressel SL, et al. Association of 3 different antihypertensive medications with hip and pelvic fracture risk in older adults: secondary analysis of a randomized clinical trial[J]. JAMA Intern Med, 2017, 177(1): 67-76. [7] Solomon DH, Ruppert K, Zhao Z, et al. Bone mineral density changes among women initiating blood pressure lowering drugs: a SWAN cohort study[J]. Osteoporos Int, 2016, 27(3): 1181-1189. [8] Nakamura A, Shimizu C, Nagai S, et al. A rare case of Gitelmans syndrome presenting with hypocalcemia and osteopenia[J]. J Endocrinol Invest,2005, 28(5): 464-468. [9] 陈宗存, 赖舒畅, 王秋怡, 等. 合并骨质疏松且无低血镁的Gitelman综合征1例[J]. 安徽医药, 2023, 27(7): 1353-1355. [10] Erem S, Atfi A, Razzaque MS. Anabolic effects of vitamin D and magnesium in aging bone[J]. J Steroid Biochem Mol Biol, 2019, 193: 105400. doi: 10.1016/j.jsbmb.2019.105400. [11] Matias P, ávila G, Ferreira AC, et al. Hypomagnesemia: a potential underlooked cause of persistent vitamin D deficiency in chronic kidney disease[J]. Clin Kidney J, 2023, 16(11): 1776-1785. [12] Belluci MM, de Molon RS, Rossa C Jr, et al. Severe magnesium deficiency compromises systemic bone mineral density and aggravates inflammatory bone resorption[J]. J Nutr Biochem, 2020, 77: 108301. doi: 10.1016/j.jnutbio.2019.108301. [13] Shi S, Lu C, Tian H, et al. Primary aldosteronism and bone metabolism: a systematic review and meta-analysis[J]. Front Endocrinol(Lausanne), 2020, 11: 574151.doi: 10.3389/fendo.2020.574151. [14] 陈瑞晗,陈珺.高盐/肾素-血管紧张素-醛固酮系统与骨代谢[J].中国骨质疏松杂志, 2017,23(11):1518-1522. CHEN Ruihan, CHEN Jun. High salt/renin-angiotensin-aldosterone system and bone metabolism[J].Chinese Journal of Osteoporosis, 2017, 23(11): 1518-1522. [15] Mo C, Ke J, Zhao D, et al. Role of the renin-angiotensin-aldosterone system in bone metabolism[J]. J Bone Miner Metab, 2020, 38(6): 772-779. [16] Walsh SB, Unwin E, Vargas-Poussou R, et al. Does hypokalaemia cause nephropathy? An observational study of renal function in patients with Bartter or Gitelman syndrome[J]. QJM, 2011, 104(11): 939-944. [17] Foglia PEG, Bettinelli A, Tosetto C, et al. Cardiac work up in primary renal hypokalaemia-hypomagnesaemia(Gitelman syndrome)[J]. Nephrol Dial Transplant, 2004, 19(6): 1398-1402. [18] Salcuni AS, Palmieri S, Carnevale V, et al. Bone involvement in aldosteronism[J]. J Bone Miner Res, 2012, 27(10): 2217-2222. |
| [1] | . [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 127-129. |
| [2] | WANG Guangjie, ZU Shulu, ZHANG Xiulin, XU Zhishun, ZHOU Chunwen, LIU Yuqiang, WANG Shaoyong. Von Hippel-Lindau disease complicated with renal carcinoma: a report of 2 cases [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(2): 86-89. |
| [3] | . [J]. Journal of Shandong University (Health Sciences), 2021, 59(8): 119-121. |
|
||
